TY - JOUR
T1 - Utility of FDG PET at the Initial Radioiodine Therapy in Differentiated Thyroid Cancer
AU - Matsuo, Mioko
AU - Baba, Shingo
AU - Hashimoto, Kazuki
AU - Isoda, Takuro
AU - Kitamura, Yoshiyuki
AU - Kogo, Ryunosuke
AU - Jiromaru, Rina
AU - Hongo, Takahiro
AU - Manako, Tomomi
AU - Nakagawa, Takashi
N1 - Funding Information:
The Authors would like to thank Editage (www.editage.com) for English language editing.
Publisher Copyright:
© 2023 International Institute of Anticancer Research. All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - Background/Aim: Differentiated thyroid cancer (DTC) has a good prognosis, except in the case of patients with radioiodine therapy (RIT)-refractory cancer. However, since DTC is essentially a slowly progressing cancer, it is usually judged to be a DTC with a poor prognosis after multiple RITs and yearly follow-up with echo, computed tomography (CT), and serum thyroglobulin values. This study investigated whether fluorodeoxyglucose-positron emission tomography/CT (FDG PET/CT) combined with initial RIT could identify early-stage patients with poor prognosis. Patients and Methods: We evaluated 100 patients with high-risk DTC who underwent total thyroidectomy and received RIT at our institution. We analyzed the clinical outcomes of patients and 18F-FDG accumulation using univariate and multivariate Cox proportional hazards regression models. Results: The 10-year overall survival (OS) was 87.9%, with no significant difference in OS between 18F-FDG accumulation at pre-total or near-total thyroidectomy (NTT) (p=0.180) and 131I accumulation at initial RIT (p=0.577). However, 18F-FDG positive patients had a significantly worse prognosis than negative patients (p=0.005) at initial RIT. Conclusion: 18F-FDG PET/CT plays an important role in both the diagnosis and prognostic prediction of RIT refractory disease in DTC patients. 18F-FDG PET/CT can be a useful tool particularly at the time of initial RIT since the 18F-FDG accumulation enables the screening of high-risk DTC with poor prognosis at a very early time stage.
AB - Background/Aim: Differentiated thyroid cancer (DTC) has a good prognosis, except in the case of patients with radioiodine therapy (RIT)-refractory cancer. However, since DTC is essentially a slowly progressing cancer, it is usually judged to be a DTC with a poor prognosis after multiple RITs and yearly follow-up with echo, computed tomography (CT), and serum thyroglobulin values. This study investigated whether fluorodeoxyglucose-positron emission tomography/CT (FDG PET/CT) combined with initial RIT could identify early-stage patients with poor prognosis. Patients and Methods: We evaluated 100 patients with high-risk DTC who underwent total thyroidectomy and received RIT at our institution. We analyzed the clinical outcomes of patients and 18F-FDG accumulation using univariate and multivariate Cox proportional hazards regression models. Results: The 10-year overall survival (OS) was 87.9%, with no significant difference in OS between 18F-FDG accumulation at pre-total or near-total thyroidectomy (NTT) (p=0.180) and 131I accumulation at initial RIT (p=0.577). However, 18F-FDG positive patients had a significantly worse prognosis than negative patients (p=0.005) at initial RIT. Conclusion: 18F-FDG PET/CT plays an important role in both the diagnosis and prognostic prediction of RIT refractory disease in DTC patients. 18F-FDG PET/CT can be a useful tool particularly at the time of initial RIT since the 18F-FDG accumulation enables the screening of high-risk DTC with poor prognosis at a very early time stage.
UR - http://www.scopus.com/inward/record.url?scp=85145338999&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145338999&partnerID=8YFLogxK
U2 - 10.21873/anticanres.16148
DO - 10.21873/anticanres.16148
M3 - Article
C2 - 36585178
AN - SCOPUS:85145338999
SN - 0250-7005
VL - 43
SP - 183
EP - 190
JO - Anticancer Research
JF - Anticancer Research
IS - 1
ER -
